PharmaCyte Biotech, Inc. entered into a Securities Purchase Agreement with accredited investors for the sale of preferred stock and warrants, raising approximately $35 million in gross proceeds.
AI Assistant
PHARMACYTE BIOTECH INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.